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MacMahon and Pugh define epidemiology as the use of knowledge on the frequency and
distribution of disease to search for determinants [1]. This paper demonstrates that a multina-
tional approach in cancer epidemiology can be of great value in at least four circumstances:
namely, the compilation and standardization ofdata, the assessment ofrisk, the pooling ofstudy
populations to obtain interpretable results, and the provision of resources for specific epidemio-
logic investigations. One or two examples are given for each category-the determination of
international cancer incidence patterns, the evaluation of the risk posed by chemicals to man,
assessment ofthe effects oflow doses ofionizing radiation, determination ofthe long-term effects
ofexposure to asbestos substitutes, and studies on the influence ofdiet on esophageal cancer.
MEASURING CANCER
Epidemiology, like any other science, is based on measurement: it is the differences
in frequency, whether incidence, mortality, or proportion, that give rise to hypotheses
[1]. (The reader may care to reflect on the problems of studying cancer etiology in a
world where the risk was uniform.) While intranational differences in cancer incidence
[2] and mortality occur, they are not usually as large as those observed between
countries. International data on cancer incidence are thus ofgreat value for hypothesis
building and verification.
Following the publication of international cancer mortality figures in 1960 by Segi
[3], the UICC assembled similar data for incidence, publishing a monograph in 1966
entitled Cancer Incidence in Five Continents, containing data from 35 registries [4]:
Volumes III [5] and IV [6] of the series were published jointly by the International
Agency for Research on Cancer and the International Association of Cancer Regis-
tries. Volume V, to appear in 1986, will contain material for 1978-1982 for 140
populations collected by 110 registries throughout the world. This resource, widely
quoted in the literature, is the fruit ofinternational collaboration.
The spectrum ofrisk is very large, ranging from five- to 100-fold for many cancers.
It could be argued that such differences reflect purely genetic influences. The change
of risk observed for many populations on migration to a new environment suggests
otherwise, however; a migrant does not change his genes in his lifetime. Kennaway [7]
was the first to realize the significance of migrant studies, writing, "the very high
incidence ofprimarycancer oftheliver found among negroes in Africa does not appear
in negroes in the UnitedStates, and is therefore notofa purely racial character. Hence,
the prevalence of this form of cancer in Africa may be due to some extrinsic factors
which could be identified." The existence of populations at contrasting risk not only
serves as a source of hypotheses but also as a means of verification. If the observed
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TABLE 1
Urban/Rural Differentials in Age-Adjusted Cancer Incidence for Lung, Prostate, and
Breast Cancer Around 1975a
Lung Cancer Prostate (M)/Breast (F)
Urban Rural Urban Rural
CancerRegistry M F M F M F M F
Fukuoka, Japan 25.2 7.9 24.3 6.0 4.1 15.8 3.8 12.1
Finland 80.9 7.1 68.7 4.1 32.1 46.7 23.2 31.8
Bas-Rhin, France 59.2 4.7 50.6 4.1 25.7 55.5 20.9 54.0
Norway 34.3 6.9 18.6 3.9 42.4 55.0 36.4 44.8
Zaragoza, Spain 41.5 3.9 18.0 3.0 22.3 48.1 19.2 19.8
NW Region,
England 91.2 17.2 38.4 6.8 20.8 54.2 12.8 37.1
aData from [10]
distribution is not consistent with the hypothesis, the latter is either incomplete or
wrong [8].
As data accumulate, time trends become available for examination [9]. These, like
urban/rural differences in incidence, acquire a new dimension when examined
internationally (Table 1). The absence ofan urban/rural differential in lung cancer in
Japan, when one exists in most other countries, and the existence ofsuch differentials
for breast cancer in Zaragoza, Spain, and for prostate cancer in the northwest region of
England [10] larger than those reported elsewhere must give rise to etiological
speculation.
MONOGRAPHS ON CHEMICAL RISK
Although there are about 4 million known chemical compounds and perhaps 60,000
new substances being synthesized each year, relatively few are manufactured in
quantities greater than 500 kg each year. As several are very widely used in industry as
food additives and as therapeutic agents, it becomes imperative to have an assessment
of their carcinogenicity. National assessments, however, are frequently made in the
context of political pressures, thus compromising the objectivity of these scientific
analyses.
The need for an impartial weighing of evidence is thus evident. The International
Agency for Research on Cancertherefore embarked on such a program nearly 20 years
ago and has now examined over 700 chemical compounds, publishing the findings in a
series of monographs entitled IARC Monographs on the Evaluation ofCarcinogenic
Risk ofChemicals to Humans [ 11]. These monographs represent a truly international
effort: experts are commissioned to write a draft on the basis ofpublished work which
is then subject to peer scrutiny at the Monograph meeting. A typical monograph gives
the structure, physical properties, production, use, occurrence, and methods of
chemical analysis ofthesubstanceunderconsideration. This information is followed by
an evaluation ofcarcinogenicity studies in animals, mutagenicity and other short-term
tests, and case reports and epidemiological studies ofcarcinogenicity in humans. A list
of chemicals for which there is sufficient evidence ofcarcinogenicity is given in Table
2. Recently, the Monograph program has extended its sphere of activity to include
habits such as smoking [12] and the use ofso-called smokeless tobacco [13].
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TABLE 2
Chemicals, Groups of Chemicals, Complex Mixtures, or Industrial Processes Associated with Cancer
in Humans (Group 1) or Highly Probably Associated with Cancer in Humans (Group 2A)
Chemicals, GroupsofChemicals, and Complex Mixtures
Group I
4-Aminobiphenyl
Analgesic mixtures with
phenacetin
Arsenic and arsenic
compounds
Asbestos
Azathioprine
Benzene
Benzidine
Betel quid with tobacco
N,N-Bis(2-chloroethyl)-
2-naphthylamine
(Chlornaphazine)
Bis (chloromethyl)
ether, technical chlo-
romethyl methyl ether
1,4-Butanediol demeth-
anesulphonate
(Myleran)
Associated CancerSites
Bladder
Renal
Lung, skin, liver
Lung, gastrointestinal
tract
Non-Hodgkin's lym-
phoma
Squamous skin, hepato-
biliary
Leukemia
Bladder
Pharynx, esophagus
Bladder
Lung
Group I
Combined chemother-
apy for lymphomas
(including MOPP,
procarbazine, nitrogen
mustard, Vincristine,
prednisone)
Chlorambucil
Chromium (hexavalent)
Coal tar
Coal tar pitch
Conjugated estrogens
Cyclophosphamide
ortho-Toluidine
Associated CancerSites
Non-lymphocytic leuke-
mia
Non-lymphocytic leuke-
mia
Lung, nasal cavities
Respiratory tract, scro-
tum
Respiratory tract, scro-
tum
Corpus uterus (post-
menopausal)
Non-lymphocytic leuke-
mia
Bladder
Non-lymphocytic leuke-
mia
Industrial Processes
Group I
Auramine manufacture
Boot and shoe manufac-
ture and repair
Coal gasification (older
processes)
Coke production
Furniture manufacture
(wood dust)
Group 2A
Iron and steel founding
Magenta manufacture
Diethylstilbestrol
Melphaian
Methoxalen with ultra-
violet A therapy
(PUVA)
Mineral oils
Associated Cancer Sites
Bladder
Nasal cavity, paranasal
sinus
Respiratory tract
Respiratory tract
Nasal cavity
Associated CancerSites
Lung
Bladder
Vagina (in utero expo-
sure)
Corpus uterus (post-
menopausal)
Non-lymphocytic leuke-
mia
Squamous skin
Respiratory tract, nasal
cavity, scrotum, squa-
mous skin
Group I
Isopropyl alcohol manu-
facture (strong acid
process)
Nickel refining
Rubber industry
Underground hematite
mining (with exposure
to radon)
Group 2A
Mustard gas
2-Naphthylamine
Shale oils
Smokeless tobacco prod-
ucts
Soots
Tobacco smoke
Treosulphan
Vinyl chloride
Associated CancerSites
Nasal cavity, larynx
Nasal cavity, paranasal
sinus
Bladder
Lung
Associated CancerSites
Lung, larynx
Bladder
Scrotum, squamous skin
Pharynx
Scrotum, squamous skin
Lung, upper GI tract,
bladder, pancreas,
kidney
Non-lymphocytic leuke-
mia
Liver, lung, brain
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TABLE 2-continued
Industrial Processes
Group 2A Associated Cancer Sites Group 2A Associated Cancer Sites
Acrylonitrile Lung Nickel and nickel com- Lung, nasal cavity
Aflatoxins Liver pounds
Benzo[a]pyrene Lung Nitrogen mustard Non-lymphocytic leuke-
Beryllium and beryllium Lung mia
compounds Oxymetholone Hepatoma
Creosote Lung Phenacetin Renal
Diethyl sulphate Larynx Procarbazine Non-lymphocytic leuke-
Dimethyl sulphate Respiratory mia
These monographs evaluate the risk; they do not attempt to suggest limits or advise
on regulatory action, as this is the prerogative of each country. They do, however,
represent a balanced international opinion.
LOW DOSES OF RADIATION
There is widespread public concern about exposure to ionizing radiation, and debate
on the effects oflow doses continues. While proponents ofhormesis [14] maintain that
exposure to small quantities of harmful agents results in selective induction of
appropriate defense mechanisms, this view is not universally held. Hence there is a
continuing need to obtain data on the risk to humans after such exposures. It is
arguable whether large-scale human studies of low-dose exposures will provide useful
information; not only are these very expensive, but it is unlikely that other important
risk factors, such as cigarette smoking, can be controlled for sufficiently. There are,
moreover, statistical reasons why large studies of low statistical power may be
misleading. It is thus important to evaluate special groups of individuals given high
doses of ionizing radiation directed to an organ with malignant diseases in whom, by
operation ofthe inverse-square law, other organs experience doses which can be classed
as low to medium. The problem is to obtain large numbers of such persons; only
international collaboration can do so.
Boice et al. [15] recently reported on the numbers of second cancers, notified to 15
cancer registries in eight countries, occurring among 182,000 women treated for
cervical cancer, 83,000 of whom received radiation therapy. (At current rates, to
accumulate this number in the entire continental U.S. would require 16 years: the
SEER [Surveillance, Epidemiology and End Results] registries supported by the U.S.
National Cancer Institute would need well over 100 years [16].) Compared to the
numbers that would have been expected, had the same risk obtained in these 182,000
women as obtained in the general pooled populations, a small excess ofsecond cancers
was observed: 5,146 against 4,736 expected, arising one or more years after treatment.
The large radiation doses experienced by nearly 83,000 women did not dramatically
alter the riskofdeveloping a second cancer: at most, about 162 of3,324 second cancers
occurring in these women could be attributed to radiation. The relative risk for
developing cancer in organs close to the cervix, in particular bladder, rectum (Fig. 1),
uterine corpus, ovary, small intestine, bone and connective tissue, and multiple
myeloma increased with time since treatment. No similar increase was seen in these
organs for the 99,424 women treated by means other than radiation.
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FIG. 1. Observed to expected ratios for cancers of selected sites among 82,616
women previously irradiated for cancer of the cervix uteri in eight countries, by
number of years after irradiation. Note that the scale for breast cancer is different
from that of the other sites. The figures situated beneath the site titles denote the
number ofcancers observed. For further details, see text. Adapted from [15J.
Only a slight excess of acute and non-lymphocytic leukemia was found among
irradiated women (Fig. 1), the relative risk being 1.3; many fewer cases were observed
than expected on the basis of current radiation risk estimates published by the
National Academy of Sciences [17]. This rather small excess risk of leukemia may be
due to low doses of radiation delivered to bone marrow outside the pelvis; it may be
assumed that the pelvic girdle marrow was destroyed or rendered inactive by the very
large doses given.
Despite substantial doses, there was little evidenceofa radiation effect for cancers of
stomach, colon, liver, and gall bladder, for malignant melanoma and other skin cancers
(Table 3). There was, however, an excess ofthyroid cancer and a lower breast cancer
risk (Fig. 1), with a relative risk of0.7 (0.6 for those under 40 years ofage and 0.8 for
other women), probably the consequence of ovarian radiation damage. There was a
large, highly significant excess oflung cancers (Fig. 1), relative risk 3.7, perhapsdue to
misclassification of metastases and, more likely, the confounding influence ofcigarette
smoking. A similar excess was observed in those not given radiation, relative risk 2.9.
While in no way changing the need to minimize exposure to radiation, these results,
which could only have been obtained by international collaboration, help set the
problem in perspective.
ARE ASBESTOS SUBSTITUTES SAFE?
Asbestos is one of the most useful minerals extant; however, it provokes mesothe-
lioma and, in combination with cigarette smoking, relative risks for lung cancer on the
order of 60 occur. Carcinogenicity is related to fiber profile. Glass fiber and rock wool
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TABLE 3
Estimated Mean Organ Dose in Rads, the Excess Number of Cancer Predicted Using NAS Risk
Estimates [17] and the Actual Numbers Observed in Organs Close, Intermediate, and Distant to the
Area Irradiated in 82,000 Women with Cervix Uteri Cancer
Estimated Mean Predicted Excess Actual Excess/Deficita
Site Organ Dose No. No.
Bladder 3,000+ 475 85
Colon 500+ 100 15
Stomach 200 60 3
Pancreas 150 25 9
Kidney 200 30 -6
Breast 35 37 -101
Thyroid 15 50 15
aCompared to non-irradiated women ofcomparable age and length offollow-up. Based on data in [15]
have been and are extensively used as replacement materials, but they, too, have
length/diameter ratios which make them apriori potentially carcinogenic.
As users of these insulating materials are also likely to have been exposed to
asbestos, it was decided toexamine the mortality, and when possible incidence, ofthose
working in the production industry. As is usual in epidemiology, it was considered
desirable to conduct studies in Europe in parallel with those under way in the United
States to see whether the same result would be obtained.
Manufacture ofthese products is characterized by relatively small plants, the use of
differing processes, and a high initial turnover oflabor, considerations which in Europe
demanded a multinational collaborative study to yield a sufficient number of exposed
persons for follow-up. From an initial list of 72 plants, 13 in seven countries met the
study criteria, namely, (a) in operation for 20 or more years, (b) ability to follow the
workforce to incidence or death from cancer (and other diseases), (c) completeness of
the cohort, (d) no significant exposure to asbestos, and (e) ability to count fibers at
various points ofthe plants.
Follow-up of the pooled cohorts of 24,609 persons was excellent: 2.2 percent were
lost to view and 3.0 percent were known to have emigrated but could not be further
traced.
The results have public health significance: a twofold excess of lung cancers for the
period thirty years or more since first employment [18,19]. Similar findings were
obtained for the U.S. (20 cases for 17,000 production workers). In a further five-year
follow-up, some 2,719 deaths occurred in the cohort compared to the 2,459
expected-a statistically significant difference with a standardized mortality ratio
(SMR) of 111, most ofthe excess being due to violence (accidents). In the absence of
this cause, the SMR fell to 102.
For lung cancer there was a significant excess for glass wool, continuous glass
filament, and rock wool process workers when compared to national rates with a trend
for the SMR to increase with time from first exposure. Using "local" lung cancer
mortality experience for comparison modified the results (Table 4). Furthermore, the
excess for glass wool and continuous filament production was no longer significant, but
that for rock wool remained unchanged. For rock wool the excess was concentrated in
the production and pre-production areas.
However, there was no pattern of lung cancer mortality in relation to duration of
employment, and there is evidence that the three- to fourfold excess risk was mainly
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TABLE 4
Standardized Mortality Ratio (SMR) for All Causes of Death and Lung Cancer
among Those Exposed to Man-Made Mineral Fibers, by Years of Follow-up:
Effect on Lung Cancer SMR of Comparison with "Local" Rather than
National Mortality
SMR Based on SMR Based on
Causes ofDeath National Mortality "Local" Mortality
All causes 111
All causes except violence 102
All cancer 111
Lung cancer
0-9 years 107 96
1-19 years 127 112
20-29 years 119 105
30+ years 173a l53a
Total 129a 111
aSignificant difference at 5 percent level
Based on data in [18] and personal communication from Saracci
concentrated among workers starting their exposure to rock wool some 40 or more
years ago, when dust-suppressive agents and resin binders were not used and batch
production methods prevailed, a process no longer used in the countries studied.
One case of mesothelioma occurred in an individual who died 13 years after
employment for less than one year.
In such studies an increase in lung cancer due to smoking is difficult to exclude, as
the smoking habits of the cohort members are usually not known. However, several
features of the results point against smoking as the sole explanation; namely, (a) the
three- to fourfold excess in risk, (b) persistence of excess when "local" populations,
which presumably would have somewhat comparable smoking habits, were used for
comparison, and (c) the mortality from other tobacco-associated disease did not follow
suit.
NUTRITIONAL DEFICIENCY AND ESOPHAGEAL CANCER
Esophagus cancer is usually a disease of males. This is true in Occidental
populations in which the risk is high and thedisease mainlydue to alcohol and tobacco.
But in those countries where the incidence in males is below 5/100,000 per year, the
sex ratio is usually 1.5 [6].
In the Asian esophageal cancer belt, which crosses from eastern Turkey to the north
of China, passing through Iran, Iraq, southern Soviet Union, and Afghanistan, rates
can be very high in females, on the order of 100 per 100,000 or more and, on occasion,
exceed those in males [21]. In Iran, at least, alcohol and tobacco cannot explain more
than a minute fraction of the cancer, particularly in women. Correlation and
case-control studies have shown that dietary factors, notably deficiency of riboflavin,
are likely to be ofimportance [22,23] although unlikely to cause cancer in the absence
ofa carcinogen (see below).
ALCOHOL-TOBACCO
The reasons for the high levels of this esophageal cancer in northwest France have
been examined systematically by Tuyns and his colleagues. Here, over 90 percent of
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the disease can be attributed to alcohol and tobacco. While each habit is independently
carcinogenic, as the risks are probably multiplicative, reduction ofone habit can have a
large effect on the overall level of risk [24]. Tuyns has shown that the influence of
tobacco is least in the middle third ofthe organ, where alcohol is more potent, and vice
versa for the upper third, findings which are physiologically plausible [25].
Tuyns has also shown that in northwest France consumption ofcertain foodstuffs is
protective, particularly those containing vitamins A and C [26]. In U.S. blacks a poor
diet has been held to explain part of the disease, due mainly to alcohol consumption
[27]. In India, an excess risk of esophageal cancer is seen in betel quid chewers who
incorporate tobacco in the chew [28].
DIETARY EXPOSURES
In recent years, interest has focused upon esophageal cancer in Iran [21] and
northeast China [29], where incidence rates in each sex exceed 100 per 100,000 people.
In Iran, comparison of high- and intermediate-risk areas (the provinces of Mazan-
deran and Guilan, respectively) showed that diet in the high-risk area was more
monotonous, more restricted, and deficient in fresh fruit and vegetables, the staple
being wheat rather than rice. Levels of aflatoxin, polycyclic aromatic hydrocarbons,
and nitrosamines were not significantly different [22,23]. Alcohol consumption was
very low in men and non-existent in women. Case-control studies, in the form of a
case-household control-household comparison, showed that even in an area of great
poverty, cases came from the lower end of the socioeconomic scale and consumed less
fresh fruit and vegetables.
Riboflavin deficiencies were shown to be widespread in the high-risk areas. An
endoscopic survey, with biopsy, showed a series of esophageal mucosal changes
denoted "esophagitis," which was considered to be pre-cancerous [30,31]. These
changes closely resembled those seen in non-human primates treated with 1-methyl
1-nitrosurea before squamous cell carcinoma appeared [32].
Opium used in the form ofSukteh was significantly more common in high- and very
high-risk areas than in those with a low risk. Sukteh is a mixture of fresh opium and
dross (pyrolyzed opium) widely used by both sexes and at all ages in the region [33]. It
has been shown to be strongly mutagenic due to the presence of a class of hitherto
unknown compounds (e.g., 2-methyl-3H-phenanthro [3,4-d] imidazol-10-ol) which
transform Syrian hamster embryocells in culture and which are probably carcinogenic
for mice and hamsters [34]. It is quite possible that other risk factors also operate in
this region [35]. O'Neill et al. [36] suggest that silica spicules in seeds may be
important; this hot tea hypothesis has never been adequately tested.
In China, comparison of high-risk (Linxian) and low-risk (Jiaoxian) populations
showed that low levels of riboflavin, retinol, and zinc were widespread, but riboflavin
deficiency was more widespread in Linxian [37]. It was thus decided to ascertain
whether combined treatment ofretinol, riboflavin, and zinc would lower the prevalence
of pre-cancerous lesions. Following consultation with and the agreement of the
population, some 305 males and the same number of females, aged 35 to 64, were
randomized to receive weekly either a placebo, or a mixtureof 15 mg ofretinol, 200 mg
riboflavin, and 50 mg zinc. Subjects were examined at entry to the study and at its
close, 131/2 months later. The final examination of 567 (93 percent) of those in the
investigation included esophagoscopy and at least two biopsies [38].
Thestudy wasoutstanding with regard to itsdesign. Thecapsules used for treatment
were packed individually in blister packs. On the reverse side of the blisters was a
492MULTINATIONAL COLLABORATION IN CANCER RESEARCH
self-adhesive label for each weekly dose with the individual's study number and the
week number printed thereon. These capsules were held by barefoot doctors, who, on
giving a weekly treatment, removed the label, stuck it to the participant's follow-up
form, adding their signatures. The follow-up forms and remaining capsules were
inspected every two months by field supervisors. Neither participants, barefoot
doctors, nor field supervisors were aware of the treatment assignment. Two months
after the start ofthe trial, compliance was assessed by measuring blood vitamins, from
a sample of 100 participants stratified by age, sex, and production brigade. This
showed that blood levels of those on placebo and on the vitamin capsules were as
expected when compared with samples taken at the beginning of the study. This is
probably the first strictly controlled nutritional intervention study in cancer epidemiol-
ogy.
It was found that this treatment regime had no effect on the esophagitis. The results
cannot be explained by bias or by confounding, as this was a randomized double-blind
study. The lack of effect of the vitamin intervention may be interpreted in several
ways:
a. The treatment period was not long enough or the dose was not sufficiently
large. As angular stomatitis and cheilosis disappeared after three weeks with a dose of
50 mg of riboflavin, this seems unlikely. The retinol dose could not have been larger
without continuous clinical monitoring.
b. Riboflavin and retinol may not induce regression ofthe esophagitis because of
the persistence ofother factors but may prevent the induction ofpre-cancerous lesions.
The natural history of chronic esophagitis may be like that of chronic atrophic
gastritis, a precursor ofgastric cancer, which seems to be irreversible. This hypothesis
would be difficult to test in that these lesions have been shown to begin early in life.
c. The original hypothesis may have been wrong.
It is evident that this cohortofpersons needs to be followed for many years, but, even
in such a high incidence area, no more than ten cases could be expected to arise from a
population of 300 persons in ten years. The search for the carcinogens responsible
continues; among those suggested to date are nitroso compounds from pickled
vegetables [35] or from fusarium-contaminated wheat [39].
It is clear that to realize the full potential of these high levels of esophageal cancer
requires not only an international but also a multidisciplinary approach.
DISCUSSION
Many problems ofenvironmental carcinogenesis can best be solved by international
collaboration. The work mentioned above typifies four distinct categories.
Compilation andStandardization ofData
Here scientists entrust their data to a central body-frequently supranational-
which engages to produce these in a standard format useful to a wide spectrum of
investigators and, implicitly, exercise a measure of quality control. Those publishing
such data must make it clear that the endeavor reflects a collaborative effort.
International Assessment ofRisk
Here, removed from the regulatory arena, scientists assess all available published
evidence and give a scientific opinion on the carcinogenicity ofthe compound, process,
or exposure under consideration.
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Pooling ofStudy Populations to Obtain Interpretable Results
The work involved in mounting, coordinating, and analyzing such studies is such
that they are not to be embarked upon lightly. Their major justifications are: (i) to
escape from the tyranny of small numbers so that a statistically robust result is
obtained, and (ii) when numbers in a given country are sufficient, to determine whether
the result is consistent and of the same magnitude in each country and population
studied-a type ofstudy well exemplified and conducted by MacMahon et al. [40] on
risk factors in breast cancer.
Provision ofResourcesfor Individual Investigations
Manyofthe most interesting cancer problems occur incountries which are unable to
exploit them to the full. Yet the study of such areas frequently can throw light on the
genesis of the same cancer in countries where the disease is less common. The studies
on nasopharynx cancer in China and North Africa [41], of Burkitt's lymphoma in
Uganda and Tanzania [42], and ofesophageal cancer in Iran and China exemplify this
approach.
To study the influence of nutrition in China and Iran on esophageal cancer in very
high-incidence areas required epidemiological and statistical expertise, experienced
endoscopists and pathologists, and a wide range of specialized biochemical and
biological investigations.
Much of this panoply of investigations was beyond local resources and the relevant
samples had to be sent abroad. One is thus faced with situations in which the study
cannot be done without external expertise or without the collaboration of local
scientists and populations. In these circumstances, it is axiomatic that every effort
should be made to share knowledge. The resulting publications must be fair to both
parties in terms ofauthorship. IARC has a rule that primary data must remain in the
country of origin for local scientists to rework should they so desire; copies are sent
abroad.
The examples chosen in this paper reflect the work and coordinating role ofIARC,
an institution which byvocation and mandate is particularly suited for such endeavors.
Many comparable studies have ofcourse been conducted by others, frequently ad hoc
groups. International collaboration is likely to be increasingly used in the solution of
problems ofenvironmental carcinogenesis.
SUMMARY
Several of the circumstances under which a multinational approach can be ofgreat
value in cancer epidemiology are examined. The examples given include:
a. the collation of data and their publication in a standard format to assess
international cancer patterns,
b. evaluation ofthe cancer risk posed by certain chemicals to man,
c. pooling of populations to obtain numbers sufficiently large for study, exempli-
fied by investigations assessing the effect of low doses of ionizing radiation and the
long-term consequences of exposures to the asbestos substitutes rock wool and glass
wool, and,
d. the provision of resources for specific epidemiologic investigations illustrated
by a dietary intervention study in a high-risk area for esophageal cancer in China.
In conducting multinational studies, particularly those involving the developing
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countries, it is axiomatic that every effort should be made to share knowledge and that
the resulting publications be fair to all parties. Primary data should remain in the
country oforigin, and copies sent to the study coordinator. International collaboration
is likely to be increasingly used in the solution of problems of environmental
carcinogenesis.
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